Upload
dr-geoffrey-maiyoh
View
98
Download
2
Tags:
Embed Size (px)
Citation preview
MBSM 713: BIOCHEMISTRY OF ANTI MICROBIAL AGENTS
Lecture Three:
1.1.AntiviralsAntivirals
2.2.AntifungalsAntifungals
3.3.Antihelmitic drugsAntihelmitic drugs
Dr. G. Kattam Maiyoh
01/23/15
GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
1
Understanding VirusesUnderstanding VirusesThey are different from other MicrobesThey are different from other Microbes
Viral replicationViral replication• A virus cannot replicate on
its own• It must attach to and enter
a host cell• It then uses the host cell’s
energy to synthesize DNA, RNA and protein.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 3
Understanding VirusesUnderstanding Viruses
Viruses are difficult to kill because they live inside the cells• Any drug that kills a virus MAY also kill cells
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 4
Anti-viral drugsAnti-viral drugs• Certain viruses
multiply in the cytoplasm but others do in the nucleus
• Most multiplication take place before diagnosis is made
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 6
Anti-Viral drugs• Many antiviral drugs are Purine or
Pyrimidine analogs.• Many antiviral drugs are Prodrugs. They
must be phosphorylated by viral or cellular enzymes in order to become active.
• Most anti-viral agents inhibits active replication so the viral growth resumes after drug removal.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 7
Antivirals how they act Key characteristics of antiviral drugsAble to enter the cells infected with virusInterfere with viral nucleic acid synthesis and/or
regulationSome drugs interfere with ability of virus to bind to
cellsSome drugs stimulate the body’s immune systemBest responses to antiviral drugs are in patients with
competent immune systemsA healthy immune system works synergistically with
the drug to eliminate or suppress viral activity
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 8
Antiviral Medications
Antiviral drugs Used to treat infections caused by
viruses other than HIV
Antiretroviral drugs Used to treat infections caused by HIV,
the virus that causes AIDS
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 9
Antiviral Drugs: Nonretroviral Mechanism of action
Inhibit viral replication (Does not necessarily mean viral DNA replication.)
Used to treat non-HIV viral infections Influenza viruses HSV (herpes simplex virus), VZV (vericella zoster virus) CMV (cytomegalovirus) Hepatitis A, B, C (HAV, HBV, NCV)
Adverse Effects Vary with each drug Healthy cells are often killed also, resulting in serious toxicities
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 10
Anti-viral drugs• Current anti-viral agents do not eliminate non-
replicating or latent virus• Effective host immune response remains
essential for the recovery from the viral infection
• Clinical efficacy depends on achieving inhibitory conc. at the site of infection within the infected cells
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 11
Anti-viral drugsAnti-viral drugs
Stages of viral replication• Cell entry – attachment
- penetration • Uncoating• Transcription of viral genome• Translation • Assembly of virion components• Release
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 12
Anti-viral drugs
Anti-herpes virus agents• Acyclovir / Valacyclovir• Famciclovir / Penciclovir • Ganciclovir / Cidofovir • Foscarnet • Trifluridine / Idoxuridine / Vidarabine
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 14
• Valacyclovir is a prodrug of Acyclovir with better bioavailability.• Famciclovir is hydrolyzed to
Penciclovir and has greatest bioavailability.• Penciclovir is used only topically
whereas Famciclovir can be administered orally.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 15
Features
PHARMACOLOGY OF ACYCLOVIR AND CONGENERS
• Acyclovir, Valacyclovir, Ganciclovir, Famciclovir, Penciclovir
• All are guanine nucleoside analogs.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 16
Mechanism of action of Acyclovir and congeners :
• All drugs are phosphorylated by a viral thymidine-kinase, then metabolized by host cell kinases to nucleotide analogs.
• The analog inhibits viral DNA-polymerase
• Only actively replicating viruses are inhibited
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 17
• Acyclovir is thus selectively activated in cells infected with herpes virus.• Uninfected cells do
not phosphorylate acyclovir.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 18
Antiviral spectrum :
• Acyclovir: HSV-1, HSV-2, VZV, Shingles.• Ganciclovir / Cidofovir : CMV• Famciclovir : Herpes genitalis and shingles• Foscarnet : HSV, VZV, CMV, HIV• Penciclovir : Herpes labialis
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 20
Pharmacokinetics of Acyclovir :–Oral bioavailability ~ 20-30% –Distribution in all body tissues including
CNS –Renal excretion: > 80% –Half lives: 2-5 hours–Administration: Topical, Oral , IV
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 21
Adverse effects of Acyclovir / Ganciclovir • Nausea, vomiting and diarrhea • Nephrotoxicity - crystalluria,
haematuria, renal insufficiency• Myelosuppression – Neutropenia and
thrombocytopenia – Ganciclovir
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 22
Therapeutic uses :Acyclovir is the drug of choice for:• HSV Genital infections• HSV encephalitis • HSV infections in immunocompromised patientGanciclovir is the drug of choice for:• CMV retinitis in immunocompromised patient• Prevention of CMV disease in transplant patients
CMV = Cytomegalovirus is a serious eye infection of the retina
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 23
Cidofovir :• It is approved for the treatment of CMV
retinitis in immunocompromised patients• It is a nucleotide analog of cytosine – no
phosphorylation required.• It inhibits viral DNA synthesis• Available for IV, Intravitreal inj, topical• Nephrotoxicity is a major disadvantage.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 24
PHARMACOLOGY OF FOSCARNET • Foscarnet is an inorganic
pyrophosphate analog • It directly inhibits viral DNA and RNA
-polymerase and viral reverse transcriptase (it does not require phosphorylation for antiviral activity)
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 28
Foscarnet • HSV-1, HSV-2, VZV, CMV and
HIV.• Oral bioavailability ~ 10-20%• Distribution to all tissues
including CNS• Administration: IV
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 29
Adverse effects of Foscarnet • Hypocalcemia and hypomagnesemia (due
to chelation of the drug with divalent cations) are common.
• Neurotoxicity (headache, hallucinations, seizures)
• Nephrotoxicity (acute tubular nephrosis, interstitial nephritis)
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 30
Therapeutic uses of Foscarnet • It is an alternative drug for• HSV infections (acyclovir resistant /
immunocompromised patient )• CMV retinitis (ganciclovir resistant /
immunocompromised patient )
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 31
Respiratory viral infectionsInfluenza –• Amantadine / Rimantadine• Oseltamivir / Zanamavir
RSV bronchiol it is –• Ribavirin01/23/15 GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC03 32
Amantadine and Rimantadine : Influenza• Prevention & Treatment of influenza A• Inhibit ion of viral uncoating by
inhibiting the viral membrane protein M2• Amantadine has anti-parkinsonian
effects.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 33
Pharmacokinetics of Amantadine
• Oral bioavailability ~ 50-90%• Amantadine cross extensively
BBB whereas Rimantadine does not cross extensively . • Administration: Oral
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 34
Neuraminidase inhibitors : Influenza Oseltamivir / Zanamavir
• Influenza contains an enzyme neuraminidase which is essential for the replication of the virus.
• Neuraminidase inhibitors prevent the release of new virions and their spread from cell to cell.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 35
Neuraminidase inhibitors : Influenza Oseltamivir / Zanamavir
• These are effective against both types of influenza A and B.
• Do not interfere with immune response to influenza A vaccine.
• Can be used for both prophylaxis and acute treatment.
Administration• Oseltamivir is orally administered.• Zanamavir is given intranasal.
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 36
Virus
Diseases Drug(s) of choice
Alternative drugs
FLU A
Influenza
Amantadine Rimantadine
RSV Pneumonia,bronchiolitis
Ribavirin(aerosol)
HSV
Genital herpes
Acyclovir
Foscarnet
Keratitis
Conjunctivitis
Trifluridine IdoxuridineVidarabine
Encephalitis
Acyclovir
Neonatal HSV
infection
Acyclovir
Vidarabine Herpes infections in
immuno- compromised host
Acyclovir
Foscarnet01/23/15 GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC03 48
VZV
In normal host
No therapy
In immunocompro-mised host, or during pregnancy
Acyclovir
Foscarnet
CMV
Retinitis
Ganciclovir
Foscarnet
HIV
AIDSHIV antibody positive with CD4 count < 500/mm3
Zidovudine ± protease inhibitors
Didanosine,Stavudine
HBVHCV
Hepatitis B, C
Interferons
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 49
Antiretroviral DrugsHAART - Highly active
antiretroviral therapy
• Includes at least three medications– “cocktails”
• These medications work in different ways to reduce the viral load
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 50
Antiretroviral Drugs• Reverse transcriptase inhibitors (RTIs)– Block activity of the enzyme reverse transcriptase, preventing
production of new viral DNA
• Include:– Nucleoside RTIs (NRTIs)– Nonnucleoside RTIs (NNRTIs)– Nucleotide RTIs (NTRTIs)
• Examplesabacavir (Ziagen) delavirdine (Rescriptor)didanosine (Videx) lamivudine (Epivir)stavudine (Zerit) tenofovir (Viread)
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 51
Antiretroviral Drugs• Protease inhibitors (PIs)– Inhibit the protease a
retroviral enzyme, preventing viral replication
– Examples:
amprenavir (Agenerase)indinavir (Crixivan)
nelfinavir (Viracept)ritonavir (Norvir)
saquinavir (Invirase)
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 52
Antiretroviral DrugsAntiretroviral Drugs• Fusion inhibitors– Inhibit viral fusion,
preventing viral replication
– Newest class of antiretroviral drugs
– Example: enfuvirtide (Fuzeon)
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 53
Antiretroviral Drugs• Combinations of multiple antiretroviral
medications are common• Adverse effects vary with each drug
and may be severe−monitor for dose-limiting toxicities• Monitor for signs of opportunistic
diseases
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 54
Antiretroviral Drugs:Antiretroviral Drugs:Adverse EffectsAdverse Effects
Numerous and vary Numerous and vary with each drugwith each drug
Drug therapy may need to be modified because of adverse effects
Goal is to find the regimen that will best control the infection with a tolerable adverse effect profile
Medication regimens change during the course of the illnessduring the course of the illness
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03 55
Antiviral Drugs Antiviral Drugs
ANTIFUNGAL DRUGS
Systemic & Topical
Some are fungistatic, while others are fungicidal
01/23/15 56GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
Fungal Infection in Humans = Mycosis
Fungal Infection in Humans = Mycosis
• Major Types of Mycoses– superficial – cutaneous – subcutaneous – systemic– opportunistic
• Symptoms vary from cosmetic to life threatening
01/23/15 57GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
Antifungal Agents• Polyene antibiotic• The polyene antibiotics bind with sterols in the fungal cell
membrane, principally ergosterol. This causes the cell's contents to leak out and the cell dies. Animal cells contain cholesterol instead of ergosterol and so they are much less susceptible.– Nystatin – Amphotericin B (may be administered liposomally) – Natamycin – Rimocidin – Filipin – Pimaricin
01/23/15 58GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
Antifungal AgentsImidazole and triazole• The imidazole and triazole groups of antifungal drugs
inhibit the enzyme cytochrome P450 14α-demethylase. This enzyme converts lanosterol to ergosterol, and is required in fungal cell membrane synthesis. These drugs also block steroid synthesis in humans.
• Imidazoles:• Miconazole Bifonazole• Ketoconazole Butoconazole • Clotrimazole Econazole• Mebendazole Fenticonazole• Isoconazole Oxiconazole • Sertaconazole Sulconazole • Thiabendazole Tiaconazole 01/23/15 60GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC03
Antifungal Agents
• The triazoles are newer, and are less toxic and more effective:• Fluconazole • Itraconazole • Ravuconazole • Posaconazole • Voriconazole
01/23/15 61GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
Antifungal Agents
Allylamines• Allylamines inhibit the enzyme squalene
epoxidase, another enzyme required for ergosterol synthesis:– Terbinafine - marketed as Lamisil – Amorolfine – Naftifine
– Butenafine
01/23/15 62GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
Antifungal AgentsEchinocandin• Echinocandins inhibit the synthesis of
glucan in the cell wall, probably via the enzyme 1,3-β glucan synthase:– Anidulafungin – Caspofungin
– Micafungin
01/23/15 63GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
Antifungal Agents• Others:– Flucytosine is an antimetabolite. –Griseofulvin binds to polymerized microtubules
and inhibits fungal mitosis; It is derived from the mold Penicillium griseofulvum. – Fluocinonide – Salicylic Acid (topical)– Tinactin or Tolnaftate–Potassium Iodide
01/23/15 64GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC03
Helminth Infections1-Tapeworms ( cestodes)
Beef tapeworm / fish tapeworm2- Intestinal round worms ( nematodes)
Ascaris, pinworm ,whipworm, strongyloides, ancylostoma ( hookworm ).
A skin infection is termed cutaneous larva migrans
Mechanism of action
• May act by causing :
• 1- paralysis of the worm.
• 2- damaging the worm leading to partial digestion or rejection by immune mechanisms.
• 3- interfere with the metabolism of the worm.
*Worms or larvae live in tissues of host
body like muscles , viscera , menninges ,
subcutaneous tissues.
• Adult filariae live in the lymphatics, connective tissue or mesentery of host and produce live embryos or microfilariae, which goes to blood stream.
• They are ingested by mosquitoes or similar insects, they develop to larvae this secondary host and pass to mouth parts of insect and
re-injected to humans
ANTHELMINTIC DRUGS
ALBENDAZOLE
• Broad spectrum oral anthelmintic
• Drug of choice for treatment of hydatid disease (tapeworm) and cysticercosis (pork tapeworm)
• It is also used for the treatment of ascariasis ,tricurasis and strongyloidiasis, pinworm, hookworm
Mechanism Of Action
1. Inhibits microtubule synthesis by binding to β –tubulin.
2. Inhibits mitochondrial reductase causing reduced glucose transport. Intestinal parasites are immobilized and die slowly.
• Larvicidal in hydatid ,cysticercosis , ascariasis and hook worm infections.
• Ovicidal in ascariasis, hookworm ,trichuriasis
Pharmacokinetics
• Formulated as Benzimidazole carbamate• Administered orally , absorption
increased with a fatty meal• Metabolized in the liver to the active
metabolite called albendazole sulfoxide
Pharmacokinetics
• Plasma half life is 8-12 hours
• sulfoxide is mostly protein bound distributes well to tissues and enters bile,CSF & hydatid cysts.
• Metabolites are excreted in urine
Clinical uses • Used on empty stomach when used against
intraluminal parasites but with a fatty meal when used against tissue parasites.
1. In ascariasis ,trichuriasis ,hookworm, pin worm infections :
2. Hydatid diseases
Albendazole (con’)
3. Neurocysticercosis: Used with corticosteroid to decrease the
inflammation caused by dying organism and it also reduces the duration of course for 21 days
4. Other infections: Drug of choice in cutaneous and visceral larva migrans , intestinal capillariasis, giardiasis & taeniasis.
Adverse Effects
• In short term(1-3 days): Mild epigastric pain,diarrhea, nausea, headache & insomnia.
• In long term use : for hydatid cyst and cysticercosis : abdominal pain, headache ,fever ,fatigue, alopecia , increased liver enzymes , pancytopenia. Blood counts and liver enzymes should be followed.
• Not given during pregnancy, hypersensitive people to benzimidazole drugs & children under 2 years .
PYRANTEL PAMOATE• Broad spectrum • Pharmacokinetics:– Poorly absorbed from GIT – Half of the drug is excreted unchanged in the feces.
• Mechanism of action:– result in paralysis of worms. It is a neuromuscular
blocking agent Efficacy – Very effective against luminal organisms( mature or
immature forms).– Not effective against migratory stages in the tissues or
against ova
Clinical uses
• Pin worm given orally with or without food.
• Ascariasis • Hookworm
Pinworm male ,female
Adverse Effects Infrequent mild transient GI disturbance
– Drowsiness , headache ,insomnia.
– Rash ,fever
Contraindications & Cautions– Should be used with caution in liver
dysfunction.
– Pregnancy
– Children under 2 years of age
PIPERAZINE• Only recommended for the treatment of ascariasis • Cure rate 90% for 2 days treatment.• Readily absorbed orally and excreted mostly unchanged
in urine
• Mechanism of action: Causes paralysis of ascaris by blocking acetylcholine at
myoneural junction , the live worms expelled by normal peristalsis.
• Treatment• Treatment is continued for 3-4 days or repeated after
one week in case of heavy infections.
Adverse Effects• GI disturbance
• Neurotoxicity ,allergic reactions .
• Contraindications
• Epilepsy or a history of epilepsy
• Impaired liver or kidney functions
• pregnancy
• Chronic neurologic disease
NICLOSAMIDE
• Second-line drug for treatment of most tapeworm infections.
• Mechanism of action:
• Adult worm( not ova) is rapidly killed by inhibition of oxidative phosphorylation .
• Pharmacokinetics:
• Poorly absorbed from gut & excreted in urine.
Clinical Uses
• Treatment of most forms of tapeworms.
• Not effective against cysticercosis or hydatic disease.
• Given in the morning on empty stomach.
• Purgative is necessary to purge all dead segments& prevent liberation of ova.
Adverse effects & Contraindications
• Mild ,infrequent and transitory GI disturbance• Alcohol consumption should be avoided• Not indicated in children under 2 years of age
or in pregnancy.
DIETHYL CARBAMAZINE
• Drug of choice for the treatment of filariasis and tropical eosinophilia.
• Pharmacokinetics:
• Rapidly absorbed from gut
• Half- life is 2-3 hours
• The drug should be given after meals
• It is excreted in urine as unchanged or metabolite.
• Dosage is reduced in urinary alkalosis and renal impairment.
Mechanism Of Action
• Immobilizes microfilariae and alters their surface structure ,displacing them from tissues & making them susceptible to destruction by host defense mechanism
• It has immunosuppressive effects
Adverse Effects
• Fever , malaise, papular rash, headache, GI disturbance,cough. Chest,muscle,joint pain
• Leucocytosis
• Retinal hemorrhage
• Encephalopathy
• lymphangitis and lymphadenopathy.
• *It is not teratogenic
IVERMECTIN
• Drug of choice for treatment of strongyloidiasis
• Macrocyclic lactone ring • Given only orally • Rapidly absorbed• Does not cross BBB.• Half- life is 16 hrs• Excretion is mainly in feces.
Mechanism Of Action
• Acts on the parasitte,s glutamate-gated Cl- channel receptors . Chloride influx increased , hyperpolarization occurs , resulting in paralysis of the worm.
Or• Paralyze nematodes by intensifying GABA-
mediated transmission of signals in peripheral nerves.
Clinical uses
• Drug of choice for cutaneous larva migrans & strongyloidiasis.
• Onchocerciasis
• It is also used for scabies , lice .
• Filariasis.
Adverse Effects
• Fatigue ,dizziness, GI disturbance
• Killing of microfilaria result in a Mazotti reaction ( fever, headache, dizziness, somnolence, hypotension , tachycardia, peripheral edema……).
• Corneal opacities & other eye lesions.
Contraindications & Cautions
• Concomitant use with other drugs that enhance GABA
e.g Barbiturates, bnzodiazepines, valproic acid.
• pregnancy
• Meningitis
• Children under 5 years of age.
BITHIONOL
• Drug of choice for the treatment of fascioliasis ( sheep liver fluke)
• Pharmacokinetics:
• It is orally administered and excreted in urine.